200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 122752-15-2
122752-15-2 | Glycinamide, L-tyrosyl-D-alanyl-L-phenylalanyl-L-α-aspartyl-L-valyl-L-valyl-
CAS No: 122752-15-2 Catalog No: AG000JAW MDL No:
Product Description
Catalog Number:
AG000JAW
Chemical Name:
Glycinamide, L-tyrosyl-D-alanyl-L-phenylalanyl-L-α-aspartyl-L-valyl-L-valyl-
CAS Number:
122752-15-2
Molecular Formula:
C37H52N8O10
Molecular Weight:
768.8564
IUPAC Name:
(3S)-3-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid
InChI:
InChI=1S/C37H52N8O10/c1-19(2)30(36(54)40-18-28(39)47)45-37(55)31(20(3)4)44-35(53)27(17-29(48)49)43-34(52)26(16-22-9-7-6-8-10-22)42-32(50)21(5)41-33(51)25(38)15-23-11-13-24(46)14-12-23/h6-14,19-21,25-27,30-31,46H,15-18,38H2,1-5H3,(H2,39,47)(H,40,54)(H,41,51)(H,42,50)(H,43,52)(H,44,53)(H,45,55)(H,48,49)/t21-,25+,26+,27+,30+,31+/m1/s1
InChI Key:
CJAORFIPPWIGPG-QXYJMILXSA-N
SMILES:
OC(=O)C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)Cc1ccccc1
Properties
Complexity:
1350
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
6
Defined Bond Stereocenter Count:
0
Exact Mass:
768.381g/mol
Formal Charge:
0
Heavy Atom Count:
55
Hydrogen Bond Acceptor Count:
11
Hydrogen Bond Donor Count:
10
Isotope Atom Count:
0
Molecular Weight:
768.869g/mol
Monoisotopic Mass:
768.381g/mol
Rotatable Bond Count:
21
Topological Polar Surface Area:
301A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.7
Literature
| Title | Journal |
|---|---|
| Analogues of deltorphin I containing conformationally restricted amino acids in position 2: structure and opioid activity. | Journal of peptide science : an official publication of the European Peptide Society 20150201 |
| ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands. | Cellular signalling 20120301 |
| Synthesis and receptor binding of opioid peptide analogues containing beta3-homo-amino acids. | Journal of peptide science : an official publication of the European Peptide Society 20091101 |
| Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. | Bioorganic & medicinal chemistry 20090601 |
| Inhibition of the development of morphine tolerance by a potent dual mu-delta-opioid antagonist, H-Dmt-Tic-Lys-NH-CH2-Ph. | Pharmacology, biochemistry, and behavior 20081001 |
| Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors. | Brain research bulletin 20080905 |
| Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists. | Cellular signalling 20080601 |
| Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure. | Bioorganic & medicinal chemistry letters 20080215 |
| Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity. | Journal of medicinal chemistry 20070419 |
| Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2). | Journal of medicinal chemistry 20070208 |
| The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of delta2-opioid receptor stimulation. | American journal of physiology. Heart and circulatory physiology 20061101 |
| Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. | Journal of medicinal chemistry 20060907 |
| Chronic morphine administration results in tolerance to delta opioid receptor-mediated antinociception. | Neuroscience 20060825 |
| Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model. | Peptides 20060501 |
| Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1). | Journal of medicinal chemistry 20051229 |
| 6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid mimics active conformation of tyrosine in opioid peptides. | Bioorganic & medicinal chemistry letters 20050516 |
| Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice. | Brain research 20050510 |
| Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050323 |
| Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040616 |
| Impact of 1,5-disubstituted tetrazole ring on chelating ability of delta-selective opioid peptide. | Journal of inorganic biochemistry 20040301 |
| An affinity label for delta-opioid receptors derived from [D-Ala2]deltorphin I. | The journal of peptide research : official journal of the American Peptide Society 20040201 |
| Effect of tetrazole moiety on coordinating efficiency of deltorphin. | Acta biochimica Polonica 20040101 |
| Fate of (D-Ala2)-deltorphin-I-like immunoreactive neurons in 6-hydroxydopamine lesioned rat brain. | European journal of histochemistry : EJH 20040101 |
| Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6. | Journal of peptide science : an official publication of the European Peptide Society 20031001 |
| Opioid peptides: synthesis and biological properties of [(N gamma-glucosyl,N gamma-methoxy)-alpha, gamma-diamino-(S)-butanoyl]4-deltorphin-1-neoglycopeptide and related analogues. | Organic & biomolecular chemistry 20030907 |
| Effects of single and dual administration of cocaine and ethanol on opioid and ORL1 receptor expression in rat CNS: an autoradiographic study. | Brain research 20030718 |
| The biological consequences of replacing hydrophobic amino acids in deltorphin I with amphiphilic alpha-hydroxymethylamino acids. | The journal of peptide research : official journal of the American Peptide Society 20030701 |
| Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists. | The Journal of biological chemistry 20030620 |
| Vas deferens response to selective opioid receptor agonists in adult mice is impaired following postnatal repeated mild stress. | European journal of pharmacology 20030101 |
| An NMR study of the solution dynamics of deltorphin-I. | Journal of the American Chemical Society 20021127 |
| Immunoreactive neurons in the brain of two mouse strains after incubation with an antiserum recognizing Asp-Val-Val-Gly.NH2 (DVVG), the C-terminal fragment of (D-Ala2)-deltorphin I. | Journal of chemical neuroanatomy 20020901 |
| Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. | Brain research 20020726 |
| Dermorphin and deltorphin heptapeptide analogues: replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity. | Bioorganic & medicinal chemistry letters 20020325 |
| Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties. | Journal of medicinal chemistry 20020131 |
| Novel C-terminus modifications of the Dmt-Tic motif: a new class of dipeptide analogues showing altered pharmacological profiles toward the opioid receptors. | Journal of medicinal chemistry 20010719 |
| Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene. | Brain research 20010706 |
| Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene. | British journal of pharmacology 20010401 |
| Synthesis and binding properties of deltorphin I analogues containing (R) and (S)-alpha-hydroxymethylnaphtylalanine. | Acta biochimica Polonica 20010101 |
| Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities. | Biochemical pharmacology 20000415 |
| Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE. | The Biochemical journal 19990815 |
| Solution conformations of deltorphin-I obtained from combined use of quantitative 2D-NMR and energy calculations: a comparison with dermenkephalin. | The journal of peptide research : official journal of the American Peptide Society 19981201 |
| Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. | The Journal of pharmacology and experimental therapeutics 19980101 |
| Structural modifications of the N-terminal tetrapeptide segment of [D-Ala2]deltorphin I: effects on opioid receptor affinities and activities in vitro and on antinociceptive potency. | Peptides 19970101 |
| TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. | Journal of medicinal chemistry 19931015 |
| In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. | The Journal of pharmacology and experimental therapeutics 19930801 |
| Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides. | International journal of peptide and protein research 19930601 |
| Conformationally restricted deltorphin analogues. | Journal of medicinal chemistry 19921016 |
| Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro. | Life sciences 19910101 |
| New features of the delta opioid receptor: conformational properties of deltorphin I analogues. | Biochemical and biophysical research communications 19900615 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.